Dr. Jianguo Zhou 周健国
Chief Physician
Department of Hepatobiliary Surgery, Cancer Hospital, Chinese Academy of Medical Sciences (National Cancer Center), Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgery-centered comprehensive treatment for hepatobiliary, pancreatic, and gastrointestinal tumors. Radical surgery for liver, bile duct, and gallbladder cancers. Complex surgeries for obstructive jaundice and retroperitoneal tumors, plus laparoscopic minimally invasive procedures.
Dr. Zhou graduated from China Medical University in 1998, earned a master’s in surgery in 2001, and a doctorate from Peking Union Medical College in 2010. Since graduation, Dr. Zhou has focused on surgical diagnosis and treatment of abdominal tumors, including gastrointestinal, hepatobiliary, pancreatic, splenic, breast, and intra-abdominal soft tissue cancers.
Professional roles
- Member, Hepatobiliary and Pancreatic Tumor MDT Professional Committee, International Hepato-Pancreato-Biliary Association China
- Member, Neuroendocrine Tumor Professional Committee, China Medical Promotion Association
- Member, National Tumor Minimally Invasive Therapy Industry Technology Innovation Strategic Alliance
- Editorial Board Member, Translational Cancer Research and Electronic Journal of Liver Cancer
Name order: in Chinese the family name comes first (Zhou Jianguo). Papers usually list the name as Jianguo Zhou or Zhou J.
Selected publications
82 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Immunother Cancer, 2026 (senior author): TCASIA: an integrative atlas linking alternative splicing landscapes for cancer immunotherapy. PubMed 42843924
- Cancer Med, 2026 (senior author): Prognostic Value of Perioperative Inflammatory-Immune-Nutritional Indicators in Advanced Gallbladder Cancer. PubMed 42834587
- Medicine (Baltimore), 2026 (senior author): Cross-sectional association between gallstone disease and nonalcoholic fatty liver disease: Exploring the mediating roles of hematological and biochemical markers. PubMed 41731811
- J Gastrointest Surg, 2020 (senior author): Resection Combined with TKI Therapy for Resectable Liver Metastases of Gastrointestinal Stromal Tumours: Results from Three National Centres in China. PubMed 31187396
- Transl Oncol, 2019 (senior author): Preoperative D-dimer and Gamma-Glutamyltranspeptidase Predict Major Complications and Survival in Colorectal Liver Metastases Patients After Resection. PubMed 31125760
- Tumour Biol, 2014 (first author): Prognostic factors of carcinoma of the ampulla of Vater after surgery. PubMed 24026886
- Chin Med J (Engl), 2014 (first author): Jaundice as a prognostic factor in patients undergoing radical treatment for carcinomas of the ampulla of Vater. PubMed 24571877
- Chin J Cancer Res, 2013 (first author): Prognostic relevance of number and ratio of metastatic lymph nodes in resected carcinoma of the ampulla of Vater. PubMed 24385702
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion